DOD OCA
@ocacademy.bsky.social
An interactive ovarian cancer virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty funded by the CDMRP/DOD.
https://www.med.upenn.edu/dodovariancanceracademy/
https://www.med.upenn.edu/dodovariancanceracademy/
ECI Mohammed Dwidar presenting at OCMF
November 11, 2025 at 2:36 PM
ECI Mohammed Dwidar presenting at OCMF
Another inspiring and successful DoD OCA workshop where science, collaboration, and camaraderie come together to push research and care forward.
September 21, 2025 at 5:47 PM
Another inspiring and successful DoD OCA workshop where science, collaboration, and camaraderie come together to push research and care forward.
September is Ovarian Cancer Awareness Month!
September 21, 2025 at 12:47 PM
September is Ovarian Cancer Awareness Month!
Reposted by DOD OCA
MD/PhD student Mihai Dumbrava from our #LabFunEpi presenting his work about an epigenetic persister cell signature using single using single cell ATAC+RNA profiling of HGSC patient samples at the AACR Ovarian cancer meeting in Denver CO.
September 20, 2025 at 9:45 PM
MD/PhD student Mihai Dumbrava from our #LabFunEpi presenting his work about an epigenetic persister cell signature using single using single cell ATAC+RNA profiling of HGSC patient samples at the AACR Ovarian cancer meeting in Denver CO.
Congratulations to DOD OCA ECI Denarda Dangaj Laniti's lab on publication revealing TIL:myeloid crosstalk as a key driver and therapeutic target in BRCA-dependent immune rewiring of recurrent ovarian cancer.
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
Ghisoni et al. profile the immune landscape of 697 ovarian cancers (OCs), identifying
four immune phenotypes linked to prognosis and treatment response. The study demonstrates
that BRCA-dependent TIL:...
www.cell.com
August 6, 2025 at 3:17 PM
Congratulations to DOD OCA ECI Denarda Dangaj Laniti's lab on publication revealing TIL:myeloid crosstalk as a key driver and therapeutic target in BRCA-dependent immune rewiring of recurrent ovarian cancer.
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
Congratulations to DOD OCA alum Jogender Tushir-Singh on recent publication showing how a human-specific mutation in FasL makes us more susceptible to cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy - Nature Communications
Fas ligand (FasL) regulates immunotherapeutic cancer-cell death. Here, the authors show a human-specific amino-acid substitution which renders human FasL more susceptible for plasmin cleavage and is r...
www.nature.com
July 17, 2025 at 1:43 PM
Congratulations to DOD OCA alum Jogender Tushir-Singh on recent publication showing how a human-specific mutation in FasL makes us more susceptible to cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Hear from OCRP leaders in this video series on how the Ovarian Cancer Academy supports researchers in making ovarian cancer the focus of their scientific careers and accelerating progress in the field:
www.youtube.com/watch?v=rC2G...
www.youtube.com/watch?v=ogO4...
www.youtube.com/watch?v=DwWV...
www.youtube.com/watch?v=rC2G...
www.youtube.com/watch?v=ogO4...
www.youtube.com/watch?v=DwWV...
OCRP Academy Video Preview 28Feb
YouTube video by CDMRP
www.youtube.com
June 10, 2025 at 6:34 PM
Hear from OCRP leaders in this video series on how the Ovarian Cancer Academy supports researchers in making ovarian cancer the focus of their scientific careers and accelerating progress in the field:
www.youtube.com/watch?v=rC2G...
www.youtube.com/watch?v=ogO4...
www.youtube.com/watch?v=DwWV...
www.youtube.com/watch?v=rC2G...
www.youtube.com/watch?v=ogO4...
www.youtube.com/watch?v=DwWV...
Congratulations to OCA alumni Drs. Dmitriy Zamarin and Juan Cubillos-Ruiz, and Deputy Dean @rdrapkin8-penn.bsky.social, on being Pershing Square Foundation Ovarian Cancer Challenge Grant recipients!
pershingsquarephilanthropies.org/news/the-per...
pershingsquarephilanthropies.org/news/the-per...
The Pershing Square Foundation Launches $5.25M Ovarian Cancer Challenge Grant to Tackle One of the Deadliest and Most Underfunded Women's Cancers — Pershing Square Philanthropies
Pershing Square Philanthropies - we bet on innovative leaders solving humanity’s big societal, environmental, and health challenges.
pershingsquarephilanthropies.org
June 10, 2025 at 6:15 PM
Congratulations to OCA alumni Drs. Dmitriy Zamarin and Juan Cubillos-Ruiz, and Deputy Dean @rdrapkin8-penn.bsky.social, on being Pershing Square Foundation Ovarian Cancer Challenge Grant recipients!
pershingsquarephilanthropies.org/news/the-per...
pershingsquarephilanthropies.org/news/the-per...
Reposted by DOD OCA
Another great #AACR meeting! Great energy, incredible science, and wonderful opportunity to connect with former trainees, colleagues, and collaborators.
@ocacademy.bsky.social
@ocacademy.bsky.social
April 29, 2025 at 6:17 PM
Another great #AACR meeting! Great energy, incredible science, and wonderful opportunity to connect with former trainees, colleagues, and collaborators.
@ocacademy.bsky.social
@ocacademy.bsky.social
www.gilead.com/stories/adva...
Features DOD OCA Alum Katherine Chiappinelli’s Lab!
Features DOD OCA Alum Katherine Chiappinelli’s Lab!
Advancing Oncology Care Through Gilead's Research Scholars Program
Gilead’s Research Scholars Program supports early-career investigators working to address unmet healthcare needs. Read more.
www.gilead.com
March 20, 2025 at 2:49 PM
www.gilead.com/stories/adva...
Features DOD OCA Alum Katherine Chiappinelli’s Lab!
Features DOD OCA Alum Katherine Chiappinelli’s Lab!
The POTEE-ntial is huge! More amazing work by our ECI Marion Curtis, uncovering TTLL8, POTEE, & PKMYT1 as new tumor antigens.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
Most high-grade serous ovarian cancers (OC) do not respond to current immunotherapies. To identify potential new actionable tumor antigens in OC, we performed immunopeptidomics on a human OC cell line...
pmc.ncbi.nlm.nih.gov
February 25, 2025 at 3:42 PM
The POTEE-ntial is huge! More amazing work by our ECI Marion Curtis, uncovering TTLL8, POTEE, & PKMYT1 as new tumor antigens.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
Amazing work done by our ECI Marion Curtis. What was once 'cryptic' in OC is now clear, hidden peptides may hold the key to powerful immune responses!
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer
Cryptic immunogenic peptides in ovarian cancer hint at their potential role in antitumor immunity.
www.science.org
February 21, 2025 at 3:47 PM
Amazing work done by our ECI Marion Curtis. What was once 'cryptic' in OC is now clear, hidden peptides may hold the key to powerful immune responses!
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Reposted by DOD OCA
Ovarian Cancer Midwest Focus conference: Flash Talk presentation first prize to my student @yiwenxie.bsky.social! Very sharp!
November 20, 2024 at 12:52 AM
Ovarian Cancer Midwest Focus conference: Flash Talk presentation first prize to my student @yiwenxie.bsky.social! Very sharp!
Reposted by DOD OCA
The Ovarian Cancer Midwest Focus (OCMF) conference at Sanford Research in Sioux Falls, South Dakota was a total blast. The keynote speakers (Don Cleveland and Denise Montell) were amazing. The flash talks by the trainees were fascinating....and Casino Night was super fun.
@pennmedicine.bsky.social
@pennmedicine.bsky.social
November 22, 2024 at 12:39 AM
The Ovarian Cancer Midwest Focus (OCMF) conference at Sanford Research in Sioux Falls, South Dakota was a total blast. The keynote speakers (Don Cleveland and Denise Montell) were amazing. The flash talks by the trainees were fascinating....and Casino Night was super fun.
@pennmedicine.bsky.social
@pennmedicine.bsky.social